Literature DB >> 1373576

CCK-receptor antagonists attenuate suppression of sham feeding by intestinal nutrients.

D P Yox1, L Brenner, R C Ritter.   

Abstract

To test the possibility that endogenous cholecystokinin (CCK) participates in suppression of sham feeding by intraintestinal nutrient infusions, we examined the effect of CCK-receptor antagonists on the suppression of sham feeding by intraintestinally infused oleic acid, maltose or L-phenylalanine (L-Phe). In addition, we monitored amylase activity in the intestinal lumen during some sham feeding experiments and measured plasma CCK in parallel experiments using intestinally infused animals that were not feeding. Suppression of sham feeding by oleic acid or maltose was attenuated by CCK-receptor antagonists, while suppression of sham feeding by L-Phe was not. Oleate infusion increased plasma CCK concentration and luminal amylase activity. Oleate-induced increase in luminal amylase activity was attenuated by a CCK-receptor antagonist. Intraintestinal maltose or L-Phe did not increase plasma CCK concentration or luminal amylase activity, suggesting that they did not release endocrine CCK. These results suggest 1) that endogenous CCK mediates suppression of sham feeding by oleate and maltose but not by L-Phe and 2) that CCK participating in suppression of feeding by intestinal stimuli might not be of endocrine origin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1373576     DOI: 10.1152/ajpregu.1992.262.4.R554

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  15 in total

1.  Lipid transport in cholecystokinin knockout mice.

Authors:  Alexandra King; Qing Yang; Sarah Huesman; Therese Rider; Chunmin C Lo
Journal:  Physiol Behav       Date:  2015-07-11

2.  Intraduodenal milk protein concentrate augments the glycemic and food intake suppressive effects of DPP-IV inhibition.

Authors:  Diana R Olivos; Lauren E McGrath; Christopher A Turner; Orianne Montaubin; Elizabeth G Mietlicki-Baase; Matthew R Hayes
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-12-18       Impact factor: 3.619

Review 3.  Peripheral neural targets in obesity.

Authors:  Amanda J Page; Erin Symonds; Madusha Peiris; L Ashley Blackshaw; Richard L Young
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

4.  Cholecystokinin knockout mice are resistant to high-fat diet-induced obesity.

Authors:  Chun-Min Lo; Alexandra King; Linda C Samuelson; Tammy Lyn Kindel; Therese Rider; Ronald J Jandacek; Helen E Raybould; Stephen C Woods; Patrick Tso
Journal:  Gastroenterology       Date:  2010-02-01       Impact factor: 22.682

5.  Differential body weight and feeding responses to high-fat diets in rats and mice lacking cholecystokinin 1 receptors.

Authors:  Sheng Bi; Jie Chen; R Ryan Behles; Jayson Hyun; Alan S Kopin; Timothy H Moran
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-04-04       Impact factor: 3.619

6.  Function and regulation of cholecystokinin octapeptide, beta-endorphin and gastrin in anorexic infantile rats treated with ErBao Granules.

Authors:  Y P Du; Y P Zhang; S C Wang; J Shi; S H Wu
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

7.  Evidence that intestinal glucagon-like peptide-1 plays a physiological role in satiety.

Authors:  Diana L Williams; Denis G Baskin; Michael W Schwartz
Journal:  Endocrinology       Date:  2008-12-12       Impact factor: 4.736

8.  CCK increases the transport of insulin into the brain.

Authors:  Aaron A May; Min Liu; Stephen C Woods; Denovan P Begg
Journal:  Physiol Behav       Date:  2016-08-26

Review 9.  Intestinal lipid-derived signals that sense dietary fat.

Authors:  Nicholas V DiPatrizio; Daniele Piomelli
Journal:  J Clin Invest       Date:  2015-02-02       Impact factor: 14.808

10.  CCK(1) receptor is essential for normal meal patterning in mice fed high fat diet.

Authors:  Michael J Donovan; Gabriel Paulino; Helen E Raybould
Journal:  Physiol Behav       Date:  2007-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.